InspireMD Ltd.'s MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
5/23/2013 9:47:26 AM
More...
|
InspireMD Ltd. Raises $23 Million for MGuard Stent
4/23/2013 8:28:39 AM
More...
|
InspireMD Ltd. to Present at Harvard Investors Group on June 27 in New York
6/26/2012 11:41:18 AM
More...
|
InspireMD Ltd. to Present at Inaugural Marcum Microcap Conference on June 20th in New York
6/18/2012 9:34:09 AM
More...
|
Asher Holzer Retires as President of InspireMD Ltd.
6/5/2012 11:09:00 AM
More...
|
InspireMD Ltd. Announces Enrollment Completion In Master Trial
5/24/2012 12:12:02 PM
More...
|
InspireMD Ltd. Announces Positive 3-Year Results from Extended MAGICAL Trial
5/17/2012 8:25:17 AM
More...
|
InspireMD Ltd. to Host Symposium on MGuard(TM) at EuroPCR in Paris
5/10/2012 12:03:43 PM
More...
|
InspireMD Ltd. Announces First Quarter 2012 Financial Results
5/8/2012 11:05:05 AM
More...
|
InspireMD Ltd. Announces Positive Clinical Data From Trial of MGuard™
2/6/2012 6:43:17 AM
More...
|
|